215
Participants
Start Date
January 31, 2006
Primary Completion Date
November 30, 2007
Study Completion Date
October 31, 2009
AZD2171
oral tablet
5-fluorouracil
intravenous infusion
Leucovorin
intravenous infusion
Oxaliplatin
intravenous infusion
Bevacizumab
intravenous infusion
Research Site, Innsbruck
Research Site, Vienna
Research Site, Wels
Research Site, Bonheiden
Ressearch Site, Brussels
Research Site, Edegem
Research Site, Ghent
Research Site, Leuven
Research Site, Winnipeg
Research Site, Moncton
Research Site, Greater Sudbury
Research Site, Kingston
Research Site, Ottawa
Research Site, Toronto
Research Site, Montreal
Research Site, Chomutov
Research Site, Nová Ves pod Pleší
Research Site, Pardubice
Research Site, Prague
Research Site, Montpellier
Research Site, Saint-Herblain
Research Site, Berlin
Research Site, Freiburg im Breisgau
Research Site, Halle
Research Site, Hanover
Research Site, Heidelberg
Research Site, München
Research Site, Stuttgart
Research Site, Genova
Research Site, La Torretta
Research Site, Milan
Research Site, Napoli
Research Site, Rozzano
Research Site, A Coruña
Research Site, Barcelona
Research Site, Madrid
Research Site, Valencia
Research Site, Zaragoza
Research Site, Glasgow
Research Site, Ipswich
Research Site, Maidstone
Research Site, Newcastle upon Tyne
Research Site, Sutton
Lead Sponsor
AstraZeneca
INDUSTRY